Compass Pathways plc said holders exercised 35,059,448 warrants issued on Jan. 13, 2025, generating about $200 million in proceeds. The company will issue 15,160,619 American Depositary Shares and, in lieu of ADSs to certain institutional investors, pre-funded warrants to buy up to 19,898,829 ADSs. Compass said it plans to use the proceeds to fund ongoing Phase 3 trials, a Phase 2b/3 PTSD trial, commercial readiness activities, and general corporate purposes, and expects its cash runway to extend into 2028.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Pathways plc published the original content used to generate this news brief via Business Wire (Ref. ID: 20260226866573) on February 26, 2026, and is solely responsible for the information contained therein.
Comments